17.10.2023 • News
Thierry Van Nieuwenhove Appointed as CEO of Quotient Sciences
UK-headquartered drug development and manufacturing organization (CDMO) Quotient Sciences has appointed Thierry Van Nieuwenhove as its new CEO, effective Oct. 16, 2023. He succeeds Mark Egerton who retires after 18 years in this role.
